How to Talk to Your Cancer Patients About Their COVID-19 Risk
A leukemia expert provides a model for how to respond to patients’ questions about cancer and their COVID-19 risk.
Patients with cancer, and especially those receiving treatment, are approaching their physicians with questions about their risk of contracting COVID-19. Mikkael Sekeres, MD, MS, Director of Cleveland Clinic Cancer Center’s Leukemia Program, offers an expert’s perspective on the existing research in his latest New York Times column. His answer to the question of whether cancer and chemotherapy increase the risk of death from COVID-19 provides a comprehensive look at existing research in patient-friendly language that can be a useful tool in communicating with your patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Read the column here.
Follow Dr. Sekeres on Twitter @MikkaelSekeres.